Current:Home > Contact-usWhatever happened to the Botswana scientist who identified omicron — then caught it?-Angel Dreamer Wealth Society D1 Reviews & Insights
Whatever happened to the Botswana scientist who identified omicron — then caught it?
View Date:2024-12-23 20:13:00
Sikhulile Moyo led the team of scientists that first identified the omicron variant of COVID-19 in November 2021. It's gone on to dominate the world. Moyo directs the laboratory for the Botswana–Harvard AIDS Institute and is a research associate with the Harvard School of Public Health.
Moyo was disturbed to see the world's reaction to the more transmissible variant. Other nations closed off travel and trade with southern African countries, including Botswana, even as they discovered the variant was already within their own borders. In fact, it was subsequently found that the variant was circulating in the Netherlands a week before the announcement from Africa.
"How do you reward the countries that alert you of a potential dangerous pathogen with travel bans? My country was put on a red list, and I didn't feel good about that," Moyo told NPR.
NPR touched base with Moyo to see what he's been working on – and thinking about – since this landmark discovery.
This interview has been edited for length and clarity.
You discovered omicron. Did omicron discover you?
I got COVID. Funnily enough, the omicron discoverer gets omicron.
I had three days of very serious symptoms of COVID, and I had to stay at home. So I would say mild to severe, but not too severe.
Then I had long COVID. I had almost three months of difficulty trying to recover my lung volume, my breathing. Walking, I was fatigued. All of a sudden, the COVID made my [blood] sugar worse, and I had to change my diabetes doses. I had to step up my meds, because it was no longer controlling [my diabetes] the way it was.
These are the complications that come with COVID, while people think COVID is gone.
Do you think the world has made any progress in learning not to cast blame?
There was a global awakening. Those events around the omicron discovery showed us the triumph of science but the failure of global health policy.
While we suffered, we were a catalyst to make people aware of the value of global public health — that we cannot be inward-looking, because the virus knows no borders.
You see the response to monkeypox is different than the response to COVID. No one is blacklisting anyone from the monkeypox-endemic areas.
Has your work changed because of this discovery — are you and your lab collaborating more with scientists around the world?
Yes! We have established collaborations with the Africa CDC. We've established what is called the Pathogen Genomics Initiative, a network of labs that are working together, and we have a lot of demand for training.
I was named one of the TIME magazine's 100 most influential people of 2022. That gives us a voice to share our experiences but also access to a lot of collaborations that I never thought I would have. That is really pushing us forward.
Have you made more ground-breaking omicron discoveries?
Earlier this year, around April, May, there was the discovery of BA.4 and BA.5, and we detected them in Botswana a few days after South Africa detected them. And these are the variants that have taken over the world. Some of the questions have been: What's happening in southern Africa that [the region] is seemingly detecting more variants?
What is unique about southern Africa, especially Botswana and South Africa, is the ability to detect these variants in near real-time because of the pathogen genomic sequencing that has been established [examining DNA to identify it or see if it's changing]. We think it's not that they are not circulating elsewhere, but it's just that maybe we are looking deeper.
We are always doing pathogen genomic sequencing. The most resourced in the world, in terms of sequencing, is of course the U.K. and the United States, and many parts of Europe. But I think the systematic, real-time, sampling and sequencing [in southern Africa] has been very, very useful.
How has southern Africa become so good at finding new variants and subvariants?
Southern Africa was the hotspot for HIV. We have passed through difficult times. I think we have taken this to our advantage to find solutions for ourselves. With funding — from PEPFAR and from other international agencies, U.S. institutes, some donors — southern Africa began to implement pathogen genomics focusing on HIV.
Some of us were involved in setting up population-based sequencing to understand the movement of viruses, to characterize transmission dynamics — and that has spilled out to malaria, to TB. And we used those technologies to quickly adapt to SARS-CoV-2. That has been the strength of southern Africa.
We're even thinking beyond COVID. We are preparing ourselves to be able to adapt for pathogen discovery. If a [new] outbreak happens, we should be able to quickly check within 24 to 36 hours what it is.
New subvariants seem to be getting better at reinfecting people. What does that mean moving forward?
BA.4 and BA.5 are masters in terms of evading the fury of the immune system. The subvariants were able to elicit an immune response, but magnitudes lower than what we saw before.
As the immunity wanes down, that's where my worry is: How far can we hold on with the current levels of immunity?
The vaccine immunity still provides some protection against severe disease. We know that you may get infected, but you may not get hospitalized with BA.4 and BA.5.
It may get a little bit rough. Many people are spending days at home and [developing] long COVID afterward.
What do you think needs to happen next?
Research, training and development cost a lot of money, but as cases go down, people forget that we need to make sure these systems are sustained. That's one of the challenges: Are we going to be able to sustain some of this innovation that we have developed over a very difficult time of our lives during COVID?
The virus is still finding some pathways to escape immune pressure.
And there's always a possibility of a more virulent variant?
The variant that is going to really dominate is a variant that would have a massive escape to antibody neutralization or to vaccine neutralization. Chances are low of that happening. But omicron taught us that anything can happen.
So we need to be very careful. We need to continue with surveillance, so that if we notice anything, we should be able to go back and say: Do we need to change the way we are doing things?
While I support loosening and going back to our lives [when cases are low], I also feel that's when you need to be more vigilant. When you see signs of wildfire starting, then you can try and put it out.
Melody Schreiber (@m_scribe) is a journalist and the editor of What We Didn't Expect: Personal Stories About Premature Birth.
veryGood! (76883)
Related
- Taylor Swift Politely Corrects Security’s Etiquette at Travis Kelce’s Chiefs Game
- Nebraska rides dominating defensive performance to 28-10 win over old rival Colorado
- Hunter Woodhall wins Paralympic sprint title to join his wife as a gold medalist
- Nashville’s Mother Church of Country Music retains its roots as religious house of worship
- A Pipeline Runs Through It
- Notre Dame upset by NIU: Instant reactions to historic Northern Illinois win
- Lil' Kim joins Christian Siriano's NYFW front row fashionably late, mid-fashion show
- Chiefs' thrilling win over Ravens is most-watched season opener in NFL history
- Wisconsin agency issues first round of permits for Enbridge Line 5 reroute around reservation
- Hope for North America’s Most Endangered Bird
Ranking
- John Robinson, former USC Trojans and Los Angeles Rams coach, dies at 89
- Cars talking to one another could help reduce fatal crashes on US roads
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Mountainsides
- Artem Chigvintsev Makes Subtle Nod to Wife Nikki Garcia After Domestic Violence Arrest
- Jordan Chiles Reveals She Still Has Bronze Medal in Emotional Update After 2024 Olympics Controversy
- Who is the highest-paid NFL player? Ranking the highest NFL contracts for 2024 season
- A mural honoring scientists hung in Pfizer’s NYC lobby for 60 years. Now it’s up for grabs
- Tyreek Hill is briefly detained for a traffic violation ahead of Dolphins’ season opener
Recommendation
-
Lee Zeldin, Trump’s EPA Pick, Brings a Moderate Face to a Radical Game Plan
-
Notre Dame's inconsistency with Marcus Freeman puts them at top of Week 2 Misery Index
-
The Best Target Products To Help Disguise Scuffs, Wires & All Your Least Favorite Parts of Your Home
-
Tom Brady's NFL broadcasting career is finally starting. What should fans expect?
-
Denzel Washington teases retirement — and a role in 'Black Panther 3'
-
Lil' Kim joins Christian Siriano's NYFW front row fashionably late, mid-fashion show
-
Wisconsin health officials recall eggs after a multistate salmonella outbreak
-
As the Planet Warms, Activists in North Carolina Mobilize to Stop a Gathering Storm